Luna, part of our Diabetes Venture Fund, closed its Series A led by Vensana Capital to advance its iCGM-compatible insulin patch pump for safer, automated nighttime care.
Luna, a Serpentine Ventures portfolio company, closed its Series A led by Vensana Capital to advance its iCGM-compatible insulin patch pump for safer, automated nighttime care.
